Related Experiment Video
Updated: Jan 24, 2026

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice
Published on: March 29, 2024
Correlation between renin-angiotensin system (RAS) related genes, type 2 diabetes, and cancer: Insights from
Luciana Xavier Pereira1, Laryssa Cristina Alves da Silva1, Alexya de Oliveira Feitosa1
1Federal University of Alagoas, Campus Arapiraca. Av. Manoel Severino Barbosa, Bom Sucesso, Arapiraca, AL, 57309-005, Brazil.
Abstract:
Although studies have provided significant evidence about the role of RAS in mediating cancer risk in type 2 diabetes mellitus (DM), conclusions about the central molecular mechanisms underlying this disease remain to be reached, because this type of information requires an integrative multi-omics approach. In the current study, meta-analysis was performed on type 2 diabetes and breast, bladder, liver, pancreas, colon and rectum cancer-associated transcriptome data, and reporter biomolecules were identified at RNA, protein, and metabolite levels using the integration of gene expression profiles with genome-scale biomolecular networks in diabetes samples. This approach revealed that RAS biomarkers could be associated with cancer initiation and progression, which include metabolites (particularly, aminoacyl-tRNA biosynthesis and ABC transporters) as novel biomarker candidates and potential therapeutic targets. We detected downregulation and upregulation of differentially expressed genes (DEGs) in blood, pancreatic islets, liver and skeletal muscle from normal and diabetic patients. DEGs were combined with 211 renin-angiotensin-system related genes. Upregulated genes were enriched using Pathway analysis of cancer in pancreatic islets, blood and skeletal muscle samples. It seems that the changes in mRNA are contributing to the phenotypic changes in carcinogenesis, or that they are as a result of the phenotypic changes associated with the malignant transformation. Our analyses showed that Ctsg and Ednrb are downregulated in cancer samples. However, by immunohistochemistry experiments we observed that EDNRB protein showed increased expression in tumor samples. It is true that alterations in mRNA expression do not always reflect alterations in protein expression, since post-translational changes can occur in proteins. In this study, we report valuable data for further experimental and clinical analysis, because the proposed biomolecules have significant potential as systems biomarkers for screening or for therapeutic purposes in type 2 diabetes and cancer-associated pathways.
Insights
This study identifies novel biomarkers in type 2 diabetes and cancer by integrating multi-omics data. These findings offer new targets for early detection and therapy in associated cancers.
Area of Science:
- Biomolecular mechanisms
- Systems biology
- Multi-omics integration
Background:
- Type 2 diabetes mellitus (DM) is linked to increased cancer risk, but underlying molecular mechanisms are unclear.
- The renin-angiotensin system (RAS) is implicated in DM-associated cancer risk.
- An integrative multi-omics approach is needed to elucidate these complex relationships.
Purpose of the Study:
- To identify novel reporter biomolecules and pathways linking type 2 diabetes and associated cancers.
- To explore the role of RAS in cancer initiation and progression within the context of type 2 diabetes.
- To discover potential systems biomarkers for screening and therapeutic targets.
Main Methods:
- Meta-analysis of transcriptome data from type 2 diabetes and various cancers.
- Integration of gene expression profiles with genome-scale biomolecular networks.
- Pathway analysis and immunohistochemistry to identify and validate biomarkers at RNA, protein, and metabolite levels.
Main Results:
- Novel biomarker candidates, including metabolites (aminoacyl-tRNA biosynthesis, ABC transporters), were identified.
- Differentially expressed genes (DEGs) were detected in various tissues between normal and diabetic patients.
- RAS-related genes and enriched cancer pathways were identified in pancreatic islets, blood, and skeletal muscle.
- Discrepancies between mRNA and protein expression (e.g., EDNRB) highlight post-translational modifications.
Conclusions:
- Metabolites involved in aminoacyl-tRNA biosynthesis and ABC transporters show potential as novel biomarkers and therapeutic targets.
- The identified biomolecules and pathways offer significant potential for screening and therapeutic strategies in type 2 diabetes and cancer.
- Further experimental and clinical analysis is warranted to validate these findings.
Related Concept Videos
The Ras Gene
Ras is a...
Diabetes Mellitus: Type 2 and Gestational
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
Correlation of Experimental Data
For example, a spherical particle moving through a viscous fluid experiences drag. Dimensional analysis shows that the drag force depends on the particle's diameter, velocity,...
Psychoneuroimmunology: Diabetes and Cancer

